Pulmonary hemosiderosis in children with Down syndrome: a national experience

Aurelia Alimi; Jessica Taytard; Rola Abou Taam; Véronique Houdouin; Aude Forgeron; Marc Lavadera; Pierrick Cros; Isabelle Gibertini; Jocelyne Derelle; Antoine Deschildre; Caroline Thumerelle; Ralph Epaud; Philippe Reix; Michael Fayon; Sylvie Roullaud; Françoise Troussier; Marie-Catherine Renoux; Jacques de Blic; Sophie Leyronnas; Guillaume Thouvenin; Caroline Perisson; Aimé Ravel; Annick Clement; Harriet Corvol; Nadia Nathan

doi:10.1186/s13023-018-0806-6

Journal articles

Pulmonary hemosiderosis in children with Down syndrome: a national experience

Aurelia Alimi ¹ Jessica Taytard ¹ Rola Abou Taam ² Véronique Houdouin ^{3, 4} Aude Forgeron ^{5, 6} Marc Lavadera ⁷ Pierrick Cros ^{8, 9} Isabelle Gibertini ¹⁰ Jocelyne Derelle ¹¹ Antoine Deschildre ^{12, 13} Caroline Thumerelle ^{12, 13} Ralph Epaud ^{14, 15} Philippe Reix ^{16, 17} Michael Fayon ^{18, 19} Sylvie Roullaud ²⁰ Françoise Troussier ^{21, 22} Marie-Catherine Renoux ²³ Jacques de Blic ² Sophie Leyronnas ¹ Guillaume Thouvenin ^{1, 24, 25} Caroline Perisson ¹ Aimé Ravel ²⁶ Annick Clement ^{1, 27, 25} Harriet Corvol ^{1, 24, 25} Nadia Nathan ^{1, 27, 25, *}

* Corresponding author

1 CHU Trousseau [APHP]

2 MaMEA Necker - Centre Référence des Maladies Héréditaires du Métabolisme de l'Enfant et de l'Adulte [CHU Necker]

3 CRI (UMR_S_1149 / ERL_8252 / U1149) - Centre de recherche sur l'Inflammation

4 RespiRare - Centre pédiatrique de pneumologie et de référence pour les maladies pulmonaires rares [AP-HP Hôpital Robert Debré]

5 Ingénierie de la vectorisation particulaire

6 Service de Pédiatrie [CH Le Mans]

Centre Hospitalier Le Mans (CH Le Mans)

7 Département de pneumologie pédiatrique [CHU Rouen]

8 Département de pneumologie pédiatrique [CHRU Brest]

9 GGB - Génétique, génomique fonctionnelle et biotechnologies (UMR 1078)

10 Département de pédiatrie [CHRU Tours]

11 Département de pédiatrie [CHRU Nancy]

12 Département de pneumologie pédiatrique [CHRU Lille]

13 CIIL - Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204

14 RespiRare - Département de pneumologie pédiatrique [CHU Créteil]

15 BCR - Biomécanique cellulaire et respiratoire

16 Evaluation et modélisation des effets thérapeutiques

Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]

17 Département de pneumologie pédiatrique [CHU Lyon]

18 Département de pneumologie pédiatrique [CHU Bordeaux]

19 BPH - Bordeaux population health

20 Département de pneumologie pédiatrique [CH Angoulême]

21 Département de pneumologie pédiatrique [CHU Angers]

22 CRCNA - Centre de Recherche en Cancérologie Nantes-Angers

23 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]

24 CR Saint-Antoine - Centre de Recherche Saint-Antoine

25 SU - Sorbonne Université

26 Institut Jérôme Lejeune

27 UMRS_933 - Physiopathologie des maladies génétiques d'expression pédiatrique

Abstract : BACKGROUND: Pulmonary hemosiderosis is a rare and complex disease in children. A previous study from the French RespiRare® network led to two important findings: 20% of the children presented with both pulmonary hemosiderosis and Down syndrome (DS), and at least one tested autoantibody was found positive in 50%. This study investigates the relationships between pulmonary hemosiderosis and DS.METHODS: Patients younger than 20 years old and followed for pulmonary hemosiderosis were retrieved from the RespiRare® database. Clinical, biological, functional, and radiological findings were collected, and DS and non-DS patients' data were compared.RESULTS: A total of 34 patients (22 girls and 12 boys) were included, among whom nine (26%) presented with DS. The mean age at diagnosis was 4.1 ± 3.27 years old for non-DS and 2.9 ± 3.45 years old for DS patients. DS patients tended to present a more severe form of the disease with an earlier onset, more dyspnoea at diagnosis, more frequent secondary pulmonary hypertension, and an increased risk of fatal evolution.CONCLUSIONS: DS patients have a higher risk of developing pulmonary hemosiderosis, and the disease seems to be more severe in this population. This could be due to the combination of an abnormal lung capillary bed with fragile vessels, a higher susceptibility to autoimmune lesions, and a higher risk of evolution toward pulmonary hypertension. A better screening for pulmonary hemosiderosis and a better prevention of hypoxia in DS paediatric patients may prevent a severe evolution of the disease.

Keywords : Children Down syndrome Pulmonary hemosiderosis Vasculitis Autoimmunity Interstitial lung disease Celiac disease Pulmonary hypertension

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Cancer

Complete list of metadata

Cited literature [34 references] Display Hide Download

https://www.hal.inserm.fr/inserm-01823418
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Tuesday, June 26, 2018 - 9:13:23 AM
Last modification on : Tuesday, January 11, 2022 - 10:35:21 AM
Long-term archiving on: : Wednesday, September 26, 2018 - 8:34:02 PM

13023_2018_Article_806.pdf

Publisher files allowed on an open archive

Pulmonary hemosiderosis in children with Down syndrome: a national experience

File

Identifiers

Collections

Citation

Export

Metrics

Pulmonary hemosiderosis in children with Down syndrome: a national experience

File

Identifiers

Collections

Citation

Export

Share

Metrics